Open AccessIncidental Discovery of a COVID-19 Infection on a Reevaluation FDG PET/CT in a Patient Treated for Hodgkin Lymphoma
Author(s) -
Célestine Simand,
Caroline Bund,
Blandine Guffroy,
Vitaliy Chaban,
Raoul Herbrecht
Publication year - 2020
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000003144
Subject(s) - medicine , asymptomatic , lymphoma , covid-19 , context (archaeology) , radiology , positron emission tomography , pet ct , stage (stratigraphy) , hodgkin lymphoma , lung , nuclear medicine , disease , infectious disease (medical specialty) , paleontology , biology
We report the results of F-FDG PET/CT in an asymptomatic case of COVID-19 infection. A 27-year-old woman underwent FDG PET/CT for revaluation of a stage IIIE B Hodgkin lymphoma after the fourth cycle of chemotherapy. It showed intense avid FDG subpleural mixed ground-glass and consolidative lesions, especially in the left lung. Because of this morpho-metabolic aspect and the epidemic context, a viral pneumopathy was suspected. The patient who was initially asymptomatic was admitted for fever 28 hours after the PET/CT. The nasopharyngeal swab was positive for COVID-19, and the outcome was favorable.